In Brief:
In a large, retrospective, multicenter cohort of lung transplant recipients, delayed-onset cytomegalovirus (CMV) disease is by far the main CMV clinical presentation, and delayed-onset CMV pneumonitis is associated with an increased risk of death.
Go to Full Text of this Article